GlassScriptPhysician profile
Elizabeth Heroux
NPI 1063174266
$7,530.46
in general payments reported to CMS, 2019-2025
46 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $204 · 2022: $1,466 · 2023: $1,940 · 2024: $2,230 · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,573 · Long Term Medical Supply Or Device Loan: $275 · Education: $12.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,573.47 |
| Long Term Medical Supply Or Device Loan | $274.95 |
| Education | $12.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $882.57 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $872.23 | 2024-2025 | Freestyle Libre, Freestyle Copilot |
| Lilly USA, LLC | $780.97 | 2021-2025 | Mounjaro, Jardiance, Baqsimi |
| Xeris Pharmaceuticals, INC. | $689.31 | 2021-2025 | Gvoke Hypopen, Recorlev, Keveyis |
| Amgen INC. | $439.75 | 2022-2025 | Evenity, Prolia, Tepezza |
| Radius Health, INC. | $433.10 | 2023-2025 | Tymlos |
| Corcept Therapeutics | $414.63 | 2022-2025 | Korlym |
| Dexcom, INC. | $274.87 | 2022-2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $239.44 | 2022-2025 | |
| Horizon Therapeutics Plc | $228.36 | 2022-2023 | Tepezza |
| Sanofi-Aventis U.S. LLC | $216.65 | 2022-2025 | |
| Baxter Healthcare | $211.70 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Astrazeneca Pharmaceuticals LP | $170.12 | 2022 | |
| Alexion Pharmaceuticals, INC. | $162.11 | 2022-2024 | Strensiq, Ultomiris |
| Renalytix Ai, INC. | $120.09 | 2024-2025 | Kidneyintelx Blood Collection Convenience Kit |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $117.15 | 2022-2025 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $116.35 | 2022-2025 | |
| United Therapeutics Corporation | $91.70 | 2023-2025 | Tyvaso, Orenitram, Remodulin |
| Merck Sharp & Dohme LLC | $91.48 | 2021-2025 | Winrevair |
| Insulet Corporation | $83.31 | 2022-2025 | Omnipod |
| Cequr Corporation | $79.28 | 2022 | |
| Electromed, INC. | $75.12 | 2022-2025 | Smartvest |
| Beta Bionics, INC. | $69.47 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ibsa Pharma INC. | $68.25 | 2022-2023 | Tirosint, Licart |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.39 | 2022-2023 | Jardiance |
| Pfizer INC. | $57.17 | 2023-2025 | |
| Tandem Diabetes Care, INC. | $41.62 | 2022 | |
| Amneal Pharmaceuticals LLC | $35.41 | 2023-2025 | Unithroid |
| Astellas Pharma US INC | $35.24 | 2023 | Veozah |
| Mylan Specialty L.P. | $29.36 | 2023 | Yupelri |
| Sequel Med Tech, LLC | $28.70 | 2025 | Twiist |
| Kyowa Kirin, INC. | $26.30 | 2024 | Crysvita |
| Almatica Pharma LLC | $26.03 | 2025 | Teriparatide |
| Actelion Pharmaceuticals US, INC. | $24.23 | 2023 | Uptravi |
| Viatris Specialty LLC | $23.65 | 2025 | Yupelri |
| Lifescan, INC. | $23.48 | 2022 | |
| Recordati_rare_diseases_inc. | $22.39 | 2025 | Isturisa |
| Regeneron Healthcare Solutions, INC. | $22.10 | 2024 | Evkeeza |
| Chiesi USA, INC. | $21.23 | 2024 | Mycapssa |
| Medtronic, INC. | $20.81 | 2025 | Inceptiv |
| Endo Pharmaceuticals INC. | $19.23 | 2022 | |
| Amryt Pharma Holdings LTD | $18.93 | 2022 | |
| Madrigal Pharmaceuticals | $17.26 | 2025 | Rezdiffra |
| Paratek Pharmaceuticals, INC. | $15.51 | 2024 | Nuzyra |
| Amphastar Pharmaceuticals, INC. | $13.74 | 2024 | Baqsimi |
| Philips North America LLC | $13.67 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Heroux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.